Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Globe Life Inc. (NYSE: GL) filings with the U.S. Securities and Exchange Commission, along with AI-generated explanations to help interpret key disclosures. Globe Life is an insurance holding company focused on life and supplemental health insurance, annuities and related investment activities, and its SEC filings offer detailed insight into these operations.
Investors can review current reports on Form 8-K, where Globe Life reports material events such as quarterly earnings releases, changes to executive retirement or compensation plans and significant financing arrangements. For example, recent 8-K filings describe the company’s second and third quarter financial results, an amendment to the Supplemental Executive Retirement Plan and the creation of a pre-capitalized trust securities (P-CAP) program that provides contingent liquidity through senior notes.
Filings also document corporate governance and executive arrangements, including early retirement reduction factors and vesting rules under the SERP in connection with change-of-control protection periods. These disclosures help clarify how Globe Life structures retirement benefits and severance protections for certain executives.
Through this page, users can track debt and capital structure–related disclosures, such as facility agreements, trust arrangements and obligations tied to senior notes and pre-capitalized trust securities. These items illustrate how Globe Life manages liquidity and long-term financing in support of its insurance and investment activities.
The platform supplements raw filings with AI-powered summaries that highlight important sections, explain technical terms and distinguish between GAAP and non-GAAP measures when referenced in attached earnings materials. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while structured data views make it easier to locate information related to executive plans, financing arrangements and reported results.
GLOBE LIFE INC. Co-Chairman & CEO Frank M. Svoboda reported exercising employee stock options for 12,500 shares on
On the same date, he sold a total of 12,500 common shares in open-market transactions, in three blocks of 3,595, 6,451 and 2,454 shares at average prices of
A holder of Globe Life Inc. common stock filed a notice of proposed sale of 12,500 shares under Rule 144. The shares are to be sold through Apex Clearing on the NYSE, with an aggregate market value listed as 1,801,250 and total shares outstanding of 78,580,771.
The seller acquired these 12,500 shares on the same date through a stock option exercise, with the consideration described as proceeds of the option exercise. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about Globe Life’s current or prospective operations.
Globe Life Inc. executive Jennifer A. Haworth, EVP & Chief Marketing Officer, exercised an employee stock option for 10,000 shares of common stock at an exercise price of
Globe Life Inc. has an affiliated holder filing a notice to sell 10,000 shares of its common stock under Rule 144. The shares are to be sold through APEX Clearing on the NYSE, with an aggregate market value of 1,471,000 and 78,580,771 shares outstanding. The approximate sale date given is 02/12/2026. The seller acquired the 10,000 shares on 02/09/2026 through a stock option exercise from Globe Life Inc., with payment dated 02/12/2026.
Globe Life Inc. executive vice president and chief financial officer Thomas P. Kalmbach reported acquiring 7,537 shares of Globe Life common stock on February 26, 2025 at a reported price of $0, leaving him with 25,780.945 shares beneficially owned directly after the transaction.
The amended filing states this total includes 17.136 shares acquired through the company’s dividend reinvestment plan since the last report and clarifies that the amendment was made to correct the beneficial ownership amount, which also affects one subsequent filing.
Globe Life Inc. director Mark A. Blinn reported an indirect sale of common stock through a trust. On 02/06/2026, the trust sold 1,750 Globe Life shares at $147.91 per share. After the sale, Blinn held 1,373 shares directly and 3,372 shares indirectly through the trust.
Globe Life Inc. director amends prior insider trade report to clarify ownership. The amended Form 4 shows that on January 6, 2025, a trust associated with the director sold 3,000 shares of Globe Life common stock at $113.235 per share.
After the sale, the director holds 1,604 shares directly and 3,518 shares indirectly through the trust. The amendment corrects the earlier filing to state that the transaction was executed from the reporting person's trust account rather than from a direct personal holding.
Globe Life Inc. director Mark A. Blinn reported an amended insider transaction. On 04/25/2024, a trust associated with him purchased 2,000 shares of Globe Life common stock at $76.77 per share. The amendment corrects the attribution of beneficial ownership to the reporting person’s trust.
After this transaction, the filing shows 5,043 shares of Globe Life common stock held indirectly through the trust and 1,475 shares held directly by Blinn.
Globe Life Inc. executive Michael Clay Majors, EVP and Chief Strategy Officer, reported stock option exercises and share sales dated February 6, 2026. He exercised employee stock options for 27,000 shares at $100.74 per share and 3,000 shares at $98.32 per share, receiving common stock.
On the same date he sold several blocks of common stock, including 11,581, 13,510, 3,488 and 1,421 shares at weighted average prices of about $146.04, $147.18, $147.92 and $148.63 per share, with detailed price ranges disclosed in the footnotes. After these transactions he directly owned 47,066 Globe Life shares and reported 0 shares held indirectly.
GL filed a notice of proposed sale of restricted securities under Rule 144. The filing covers the planned sale of 1,750 shares of common stock through Stifel Nicolaus & Company on the Nasdaq market with an aggregate market value of $258,843.00.
The shares relate to prior grants of restricted stock units from the issuer, with acquisitions dated July 3, 2023, April 25, 2024, and July 24, 2024. GL had 79,605,800 shares of common stock outstanding as of the figures shown, which is a baseline ownership figure rather than the amount being sold.